00928 KING INTL INV
- 0.076
- 0.0000.00%
KING INTL INV News
Agency: The synthetic biology sector showed a high increase in Q1 performance, and policy expectations accelerated valuation repair
Currently, the core competitiveness of biological manufacturing companies lies in product development and implementation capabilities. They are optimistic about targets with successful cases, leading positions, high-quality product reserves, and a boom in downstream demand.
Zhou Chunyan sold 380 million common shares of Imperial International Investment (00928.HK) off the market, worth approximately HK$12.617,700
On May 3, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 3, Zhou Chunyan sold $380 million ordinary shares of $Imperial International Investment (00928.HK) on April 29 at an average price of HK$0.0332 per share, worth approximately HK$12.617,700. After the sale, Zhou Chunyan's latest shareholding was 0 shares, and the good position ratio dropped from 20.54% to 0.00%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Listed public
Imperial International Investment (00928.HK) received an additional 380 million shares of common stock from Wei Yan, worth approximately HK$12.617,700
On May 3, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 3, Wei Yan increased her OTC share holdings of $Emperor International Investment (00928.HK) by $380 million at an average price of HK$0.0332 per share on April 29, worth about HK$12.617,700. After increasing her holdings, Wei Yan's latest shareholding was 380 million shares, and the good position ratio increased from 0.00% to 20.54%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. public
Imperial International Investment (00928.HK) received an additional 380 million shares of common shares worth approximately HK$126 million off the market by Wei Yan
On May 3, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 3, Wei Yan increased her OTC share holdings of $380 million of Imperial International Investment (00928.HK) shares at an average price of HK$0.332 per share on April 29, worth about HK$126 million. After increasing her holdings, Wei Yan's latest shareholding was 380 million shares, and the good position ratio increased from 0.00% to 20.54%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Directors of listed companies
Imperial International Investment (00928.HK) received an additional 380 million shares of common shares worth HK$28.84 million off the market by Wei Yan
On May 2, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 2, Wei Yan increased her OTC share holdings of $Emperor International Investment (00928.HK) by $380 million at an average price of HK$0.076 per share on April 29, worth about HK$28.84 million. After increasing her holdings, Wei Yan's latest shareholding was 380 million shares, and the good position ratio increased from 0.00% to 20.54%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Listed companies
Imperial International Investment (00928): Zheng Yu was appointed as an independent non-executive director
Imperial International Investment (00928) announced that Long Jinbo is no longer an executive director; Gu Jianguo is no longer an independent and non-executive...
Imperial International Investment (00928.HK): Wong Ka-shing Appointed as Joint Company Secretary and Authorized Representative
Gelonghui, March 14 | Imperial International Investment (00928.HK) announced that Xu Hongqun has resigned as the company's joint company secretary and no longer serves as the company's authorized representative under section 3.05 of the Hong Kong Stock Exchange Limited's securities listing rules and authorized representative to receive legal process documents and notifications in Hong Kong on behalf of the company under Part 16 of the Hong Kong Law Chapter 622 Companies Ordinance. Wong Ka-shing has been appointed as Joint Company Secretary, an authorized representative under the Listing Rules and an authorized representative to receive legal process documents and notifications in Hong Kong on behalf of the company under Part 16 of the Companies Ordinance, Chapter 622 of the Hong Kong Laws.
A major favorable raid, and the 1.6 trillion innovative drug sector is booming!
The advantage suddenly “smashed” into the pharmaceutical sector!
A quick overview of the Hong Kong market | The Hang Seng Index rose nearly 2%, and the Science Index rose nearly 3%; insurance, real estate and other sectors were strong throughout the day
Technet stocks were strong. Meituan rose nearly 5%, Bilibili and Kuaishou rose more than 3%, Xiaomi and Jingdong rose more than 2%, Baidu, Ali, and Tencent rose more than 1%, and NetEase followed; insurance stocks were strong throughout the day. China Ping An rose more than 6%, China Life Insurance rose nearly 5%, and AIA Insurance rose more than 2%.
Intraday Overview | The three major indices rose slightly, and the Tech Index rose nearly 2%; auto stocks and biotech stocks rose strongly. NIO rose nearly 8%, and Pharmaceutical Biotech rose more than 9%
Most Technology Network stocks rose, with Station B up more than 4%; Meituan and NetEase up more than 3%; mobile phone equipment stocks showed active performance, with Shunyu Optical Technology up more than 7% and Gaowei Electronics by more than 5%; pharmaceutical distribution stocks improved, Ali Health rose more than 8%, and JD Health rose nearly 5%.
Intraday Overview | The Tech Index fell more than 2%, Apple concept stocks and pharmaceutical stocks had the highest declines, and Shunyu Optical Technology fell more than 8%
Technet stocks collectively weakened, with Xiaomi falling nearly 4%, Meituan falling nearly 3%, and Kuaishou falling more than 2%; domestic housing stocks continued to decline, with Country Garden falling more than 3%; Longhu Group, Xincheng Development, and Sunac China falling nearly 2%; auto stocks were weak, with Zero Sports Auto and NIO falling more than 5%, and Xiaopeng Motors falling more than 4%.
Huang Yifeng sold 445 million shares of Imperial International Investment (00928.HK) common shares worth approximately HK$496.67 million off the market
On January 29, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 29, Huang Yifeng sold $445 million ordinary shares of $Imperial International Investment (00928.HK) on January 15 at an average price of HK$0.1116 per share, worth approximately HK$496.67 million. After the sale, Huang Yifeng's latest shareholding was 3 million shares, and the good position ratio dropped from 24.18% to 0.16%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their shares in listed companies
King International Investment Redesignates Co-Chairman as Chairman
King International Investment (HKG:0928) has redesignated co-chairman Wang Mengyao as its chairman effective today, Friday. Wang is currently the executive director of the education software products
Imperial International Investment (00928.HK): Wang Mengyao re-appointed as Chairman of the Board
Gelonghui, January 19, 丨 Imperial International Investment (00928.HK) issued an announcement. Wang Mengyao has been reassigned as the chairman of the company's board of directors, effective January 19, 2024.
Imperial International Investment (00928.HK) received an additional 445 million shares of common stock from Wang Mengyao on the market, worth approximately HK$496.67 million
On January 17, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 17, Wang Mengyao increased his OTC share holdings of $Imperial International Investment (00928.HK) by $445 million at an average price of HK$0.1116 per share on January 15, worth approximately HK$496.67 million. After the increase in holdings, Wang Mengyao's latest shareholding was 445 million shares, and the good position ratio increased from 0.00% to 24.02%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their shares in listed companies
King International Investment Shareholders to Vote Jan. 31 on Share Consolidation
Shareholders of King International Investment (HKG:0928) will meet Jan. 31 to vote on its proposed 5-for-1 share consolidation scheme, according to a Wednesday filing. Under the scheme, five shares at
King International Investment Names, Redesignates Co-Chairmen
King International Investment (HKG:0928) has hired Wang Mengyao and redesignated Liu Mingqing as co-chairmen of the company effective today, Thursday. Wang is currently an executive director, while Li
Imperial International Investment (00928.HK) appoints Wang Mengyao as Co-Chairman of the Board
Gelonghui, December 28, 丨 Imperial International Investment (00928.HK) announcements are effective from December 28, 2023:1. Mr. Wang Mengyao has been appointed as the co-chairman of the company's board of directors; 2. Mr. Liu Mingqing has been reassigned as co-chairman of the company's board of directors; and 3. Mr. Lu Xingwu has been appointed as the company's executive director.
Imperial International Investment (00928.HK) plans to sell 65% of Beijing Lianhe Health Management's shares for 23.6 million yuan
Gelonghui, December 22|Imperial International Investment (00928.HK) announced that on December 18, 2023, the seller (a wholly-owned subsidiary of the company) signed a sale agreement with the buyer. Based on this, the company agreed to sell sales rights to the buyer at a total cost of RMB 23.6 million. Sales rights account for 65% of the registered capital of the target company, Beijing Lianhe Health Management Co., Ltd. Target Group is mainly engaged in the development of major health markets in China, such as intelligent medical examinations, distribution of medical supplies and equipment, Internet medical technology, and medical research and development for public health care in rural areas. The director believed that the sale was superior to that
Lianhe Healthcare (00928.HK): Liu Mingqing appointed as Chairman of the Board
Gelonghui on December 19丨Lianhe Healthcare (00928.HK) announced that the following changes will take effect from December 18, 2023: Liu Mingqing has been appointed as the company's board chairman; Long Jinbo has been appointed as the company's executive director; Lou Tao has been appointed as the company's independent non-executive director; and Zhong Yulin has been appointed as the company's joint company secretary.
Analysis
Price Target
No Data
